Nasacort approved in 2- to 5-year-olds

A new allergy drug for children will soon be on the market: The FDA has approved Sanofi-Aventis' Nasacort for children between the ages of 2 and 5 years old for the treatment of allergies. The FDA previously approved the medication for the treatment of individuals who were at least 6 years old. Sanofi release

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.